» Articles » PMID: 39411204

Role of ENPP1 in Cancer Pathogenesis: Mechanisms and Clinical Implications (Review)

Overview
Journal Oncol Lett
Specialty Oncology
Date 2024 Oct 16
PMID 39411204
Authors
Affiliations
Soon will be listed here.
Abstract

Cancer is a significant societal, public health and economic challenge in the 21st century, and is the primary cause of death from disease globally. Ectonucleotide pyrophosphatase/phosphodiesterase (ENPP) serves a crucial role in several biochemical processes, including adenosine triphosphate hydrolysis, purine metabolism and regulation of signaling pathways. Specifically, ENPP1, a type II transmembrane glycoprotein and key member of the ENPP family, may be upregulated in tumor cells and implicated in the pathogenesis of multiple human cancers. The present review provides an overview of the structural, pathological and physiological roles of ENPP1 and discusses the potential mechanisms of ENPP1 in the development of cancers such as breast, colon, gallbladder, liver and lung cancers, and also summarizes the four major signaling pathways in tumors. Furthermore, the present review demonstrates that ENPP1 serves a crucial role in cell migration, proliferation and invasion, and that corresponding inhibitors have been developed and associated with clinical characterization.

References
1.
Montalvo-Jave E, Rahnemai-Azar A, Papaconstantinou D, Deloiza M, Tsilimigras D, Moris D . Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surg Oncol. 2019; 31:83-89. DOI: 10.1016/j.suronc.2019.09.006. View

2.
Carozza J, Brown J, Bohnert V, Fernandez D, AlSaif Y, Mardjuki R . Structure-Aided Development of Small-Molecule Inhibitors of ENPP1, the Extracellular Phosphodiesterase of the Immunotransmitter cGAMP. Cell Chem Biol. 2020; 27(11):1347-1358.e5. PMC: 7680421. DOI: 10.1016/j.chembiol.2020.07.007. View

3.
Bageritz J, Goidts V . Functional characterization of ENPP1 reveals a link between cell cycle progression and stem-like phenotype in glioblastoma. Mol Cell Oncol. 2016; 1(3):e964028. PMC: 4905057. DOI: 10.4161/23723548.2014.964028. View

4.
Li L . Stimulating STING for cancer therapy: Taking the extracellular route. Cell Chem Biol. 2024; 31(5):851-861. DOI: 10.1016/j.chembiol.2024.04.004. View

5.
Nolan E, Lindeman G, Visvader J . Deciphering breast cancer: from biology to the clinic. Cell. 2023; 186(8):1708-1728. DOI: 10.1016/j.cell.2023.01.040. View